Affiliation:
1. College of Medical Sciences, University of Rzeszów, 35-315 Rzeszów, Poland
2. St. Louis Provincial Specialist Children’s Hospital, 31-503 Kraków, Poland
Abstract
The Bacillus Calmette–Guérin (BCG) vaccine has been in use for over 100 years. It protects against severe, blood-borne forms of tuberculosis. Observations indicate that it also increases immunity against other diseases. The mechanism responsible for this is trained immunity, an increased response of non-specific immune cells in repeated contact with a pathogen, not necessarily of the same species. In the following review, we present the current state of knowledge on the molecular mechanisms responsible for this process. We also seek to identify the challenges facing science in this area and consider the application of this phenomenon in managing the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.
Subject
Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis
Reference68 articles.
1. BCG-induced trained immunity: Can it offer protection against COVID-19?;Netea;Nat. Rev. Immunol.,2020
2. Zwerling, A., Behr, M.A., Verma, A., Brewer, T.F., Menzies, D., and Pai, M. (2011). The BCG World Atlas: A database of global BCG vaccination policies and practices. PLoS Med., 8.
3. Comparative genomics of BCG vaccines by whole-genome DNA microarray;Behr;Science,1999
4. World Health Organization (2021). Global Tuberculosis Report 2021, World Health Organization.
5. World Health Organization (2011). Recommendations to Assure the Quality, Safety and Efficacy of BCG Vaccines, World Health Organization.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献